01 · The Question
How do you describe benefits when research outcomes are inherently uncertain?
Researchers usually believe their studies matter. A project may improve understanding of a problem, inform future practice, contribute evidence, or eventually help a particular population. The difficulty begins when those aspirations are written as though the study itself will deliver them.
"Participants will benefit from improved well-being." "The findings will improve institutional policy." "This research will lead to better treatment." Each statement may describe something the researcher hopes for, but unless the study can reasonably deliver that outcome, the language overstates what participation or the research can promise.
An ethics application needs a more disciplined account of potential benefit. Reviewers should be able to distinguish what individual participants may receive from what the research may contribute to other people, future practice, or knowledge.
03 · What You Need to Know
Not everything positive about a study is the same kind of benefit
Potential benefits matter because ethics review commonly considers them alongside research risks and burdens. Under the U.S. Common Rule, for example, covered research must have risks that are reasonable in relation to anticipated benefits to participants, if any, and the importance of the knowledge that may reasonably be expected to result. The World Medical Association's 2024 Declaration of Helsinki similarly requires assessment of predictable risks and burdens in comparison with foreseeable benefits for participants and other individuals or groups affected by the condition under investigation.
These frameworks have particular scopes, and your own committee may use different terminology. The underlying writing problem is broadly useful: "benefit" can refer to several different things, and combining them into one optimistic paragraph makes ethical assessment harder.
Direct participant benefit means something participants may gain from participation itself
A direct research benefit is a favorable outcome that participants may receive because of the research intervention, procedure, or participation itself. Whether such a benefit exists depends entirely on the study.
In some clinical research, an investigational intervention might offer the possibility of therapeutic benefit, although that benefit may be uncertain. In other research, participants may receive useful individual information or another meaningful outcome resulting directly from participation.
Many studies, however, offer no direct benefit to participants. An interview, anonymous survey, observational study, or collection of data for future knowledge may contribute valuable evidence without improving the individual participant's circumstances.
It is entirely acceptable to say so. "There is no expected direct benefit to participants" can be more ethically informative than manufacturing a personal benefit because the form contains a box labeled Benefits.
Benefit to others is different from direct participant benefit
A study may reasonably be expected to contribute knowledge that could eventually help a population, profession, institution, community, or future patients even when the people currently participating receive no direct benefit.
That broader value should be described at the level supported by the study.
A small exploratory interview study might improve understanding of a poorly documented experience. It usually cannot promise that policy will change. A validation study might provide evidence about a measurement instrument. It does not necessarily improve clinical outcomes. A survey may identify patterns worth investigating further without solving the underlying problem.
Direct participant benefit
A favorable outcome an individual participant may receive as a consequence of research participation.
Broader or societal benefit
Potential value arising from the knowledge generated by the study for other people, communities, practice, policy, or future research.
Keeping these categories separate makes it much easier to avoid promising participants that they personally will receive an outcome that actually depends on future research or decisions made by others.
Knowledge can have value without immediately changing practice
Researchers sometimes oversell benefits because "contributing to knowledge" sounds modest. But producing reliable and useful knowledge is the central purpose of much research.
A study can be valuable because it estimates an association more accurately, documents an underexplored experience, tests an intervention, identifies uncertainty, challenges an assumption, develops a method, or supplies evidence for later work.
None of those contributions needs to be inflated into "this study will transform policy" to be meaningful.
The World Medical Association's Declaration of Helsinki emphasizes that medical research involving human participants should be designed to produce reliable, valid, and valuable knowledge. That framing is useful: scientific and social value can justify research without requiring researchers to predict downstream effects they do not control.
Do not confuse compensation with benefit
Payment, reimbursement, gifts, course credit, or other incentives may be important aspects of participation, but they should not automatically be counted as research benefits when assessing whether the risks of the research are reasonable.
Under the U.S. Common Rule, the IRB's risk-benefit assessment considers anticipated benefits to participants and the importance of the knowledge expected to result. Payment arrangements raise related but distinct questions, including whether they could unduly influence participation.
Keeping compensation conceptually separate also improves participant communication. A person should be able to distinguish "You will receive this payment for your time" from "You may receive this potential benefit from participating."
Do not count ordinary services as research benefits unless participation changes access to them
Another common source of inflation occurs when participants would receive a service, treatment, education, or other resource even if they did not join the study.
Under the U.S. Common Rule, the IRB considers only risks and benefits that may result from the research when applying its regulatory risk-benefit criterion, distinguishing them from risks and benefits of therapies participants would receive even without participating.
The exact rule applicable to your study may differ, but the conceptual question remains useful: is this favorable outcome actually caused by research participation, or would the person receive it anyway?
Use verbs that preserve uncertainty
Wording matters because verbs quietly turn possibilities into promises.
| Overstated wording |
More defensible wording |
Why it is better |
| The study will improve teaching practice. |
The findings may inform future efforts to improve teaching practice. |
It does not assume that evidence will automatically produce implementation or improvement. |
| Participants will gain greater self-awareness. |
Some participants may find reflecting on their experiences personally meaningful, but this is not guaranteed. |
It acknowledges individual variation and uncertainty. |
| This research will benefit future patients. |
The study may contribute evidence relevant to future research or care. |
It avoids promising downstream outcomes outside the study's control. |
| The intervention will reduce symptoms. |
The study is designed to evaluate whether the intervention reduces symptoms. |
It does not assume the result the research is intended to test. |
Words such as "may," "could," and "potential" are appropriate when uncertainty is genuine. They should not, however, become a license to attach any imaginable positive outcome to the study. A potential benefit still needs a plausible connection to the research.
Do not present the research hypothesis as a participant benefit
This is especially important in intervention studies. If your research question is whether an intervention improves an outcome, you cannot simultaneously present improvement as an established benefit of participation unless independent evidence supports that claim in the context in which you are using it.
The study may be testing whether the intervention works precisely because the answer is uncertain.
Watch Out
Be particularly careful when prospective participants may confuse research with individualized treatment or guaranteed improvement. The description of potential benefits should preserve the uncertainty that makes the research necessary in the first place.
Benefits in recruitment materials should also remain balanced
Benefit claims do not become less ethically important because they appear in an advertisement rather than the application.
OHRP guidance for U.S.-regulated clinical-trial recruitment materials warns against misleading prospective participants by promising benefits or implying benefits beyond those potentially provided by the research. The same practical principle is useful more broadly: recruitment should not advertise uncertain research outcomes as reasons people can expect to gain from enrolling.
If your study uses advertisements, emails, posters, websites, or other invitations, make sure any benefit language agrees with the ethics application and participant information. Depending on the applicable review system, recruitment materials may themselves require ethics approval.
The risk-benefit assessment is not an arithmetic equation
It can be tempting to imagine ethics review as a balance sheet: three risks on one side, four benefits on the other, therefore approval.
Ethical evaluation does not work that way. The seriousness and likelihood of risks matter, the nature and plausibility of benefits matter, and the scientific or social value of the knowledge matters. A vague claim that "society will benefit" does not cancel a substantial participant risk.
That is why risks also need proportionate explanation rather than rhetorical minimization. Both sides of the assessment depend on accurate characterization.
04 · A Practical Example
Turn an aspirational benefit statement into a defensible one
Hypothetical Example
An interview study about first-year teachers
Suppose researchers plan to interview first-year teachers about difficulties they encounter during their transition into professional practice. The initial application states: "Participants will benefit by becoming better teachers, while the study will improve teacher-training programs and educational policy."
The study cannot guarantee any of those outcomes. An interview may prompt reflection, but it is not an intervention designed to improve teaching performance. The researchers also do not control how institutions or policymakers use the eventual findings.
Direct benefit
The researchers could state that no direct personal benefit is expected. Some participants may value the opportunity to reflect on their experiences, but this should not be presented as guaranteed.
Knowledge contribution
The study may improve understanding of the challenges reported by first-year teachers in the population being studied.
Possible downstream value
The findings may inform future research or discussions about teacher support and preparation, subject to the study's findings and limitations.
What not to promise
The application should not claim that the interviews will make participants better teachers or that the findings will necessarily change training programs or policy.
The revised account sounds less dramatic, but it is more informative. It tells reviewers what value the study can plausibly generate without converting hopes about eventual impact into outcomes the research guarantees.
07 · A Quick Checklist
Check whether your benefit claims are defensible
Before submitting the benefits section, check:
Direct benefits to individual participants are distinguished from broader benefits to other people, communities, practice, or knowledge.
If no direct participant benefit is expected, the application says so rather than manufacturing one.
Each claimed potential benefit has a plausible connection to the study's procedures or expected knowledge contribution.
Uncertain outcomes are described as uncertain rather than promised.
The research hypothesis is not presented as though the study has already demonstrated it.
Compensation, reimbursement, incentives, and ordinary services are not misleadingly presented as direct research benefits.
Possible downstream effects such as policy or practice change are described at a level proportionate to what the study can realistically influence.
Benefit statements are consistent across the application, participant information, consent materials, and recruitment materials.